Neurofilament light chain (NfL), total tau protein, glial fibrillary acidic protein (GFAP), and chitinase 3-like-1 (CHI3L1) are promising prognostic biomarkers for MS. This evidence concerns the gene MAPT and myeloid sarcoma.